human stem cells

BIOLOGICAL2 trials

Sponsors

University of Leipzig, Celavie Bioscences, LLC

Conditions

Acute Myeloid LeukaemiaIdiopathic Parkinson Disease

Phase 1

Parkinsonian Brain Repair Using Human Stem Cells

Celavie Bioscences, LLCIdiopathic Parkinson Disease

Start: 2014-05-31End: 2018-12-31Updated: 2016-06-13

Phase 3

Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML>60a

CompletedNCT01497002

University of LeipzigAcute Myeloid Leukaemia

Start: 2005-04-30End: 2018-07-18Updated: 2024-01-31

Related Papers

Comparison of Treatment Strategies in Patients over 60 Years with AML: Final Analysis of a Prospective Randomized German AML Intergroup Study

Blood2016-12-027 citations

Hematopoietic stem cell transplantation (HSCT) compared to consolidation chemotherapy (CT) to increase leukemia free survival (LFS) in acute myelogenous leukemia (AML) patients between 60 and 75 years irrespective of genetic risk: Report from the AML 2004 of the East German Study Group (OSHO).

Journal of Clinical Oncology2016-05-207 citations